[SGMO] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 9.83%
YoY- -112.62%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 21,553 13,076 54,851 21,958 17,548 8,071 26,837 -13.61%
PBT -35,965 -42,974 4,501 -27,361 -30,356 -42,203 -19,219 51.91%
Tax -36 -61 179 -54 -72 -53 -1,246 -90.60%
NP -35,929 -42,913 4,555 -27,307 -30,284 -42,150 -18,664 54.81%
Tax Rate - - -3.98% - - - - -
Total Cost 57,482 55,989 50,296 49,265 47,832 50,221 45,501 16.87%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -166.70 -328.18 8.30 -124.36 -172.58 -522.24 -69.55 79.19%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.26 -0.37 0.04 -0.24 -0.26 -0.41 -0.18 27.80%
EPS Diluted -0.26 -0.37 0.04 -0.24 -0.26 -0.41 -0.18 27.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.